Breast Cancer: Clinical Trials

Department of Health and Social Care written question – answered on 27th April 2021.

Alert me about debates like this

Photo of Philippa Whitford Philippa Whitford Shadow SNP Spokesperson (Health and Social Care), Shadow SNP Spokesperson (Europe)

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 June 2020 to Question 56022, what plans his Department has to recover and restart recruitment to breast cancer clinical trials.

Photo of Jo Churchill Jo Churchill The Parliamentary Under-Secretary for Health and Social Care

The Department’s National Institute for Health Research (NIHR) is supporting the National Health Service to deliver clinical research through the Clinical Research Network (CRN).

The NIHR’s CRN reports that of the 92 breast cancer clinical trials that it was supporting on 21 May 2020, 36 or 39% were paused as a result of the COVID-19 pandemic. As of 15 April 2021, 30 or 83% of these paused breast cancer trials have restarted and 30 new breast cancer trials have entered the portfolio since 21 May 2020.

To enable clinical research studies that have been paused to restart and recruit successfully, including breast cancer trials, plans are being developed to manage the delivery of non-COVID-19 studies to ensure successful recovery of the portfolio. Details of these plans will be published shortly.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.